Cargando…

The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics

BACKGROUND: The MTNR1B gene encodes a receptor for melatonin, a hormone regulating biorhythms. Disruptions in biorhythms contribute to the development of type 2 diabetes mellitus (T2DM). Genetic studies suggest that variability in the MTNR1B gene affects T2DM development. Our aim was to compare the...

Descripción completa

Detalles Bibliográficos
Autores principales: Vejrazkova, Daniela, Vankova, Marketa, Vcelak, Josef, Krejci, Hana, Anderlova, Katerina, Tura, Andrea, Pacini, Giovanni, Sumova, Alena, Sladek, Martin, Bendlova, Bela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207528/
https://www.ncbi.nlm.nih.gov/pubmed/35733780
http://dx.doi.org/10.3389/fendo.2022.868364
_version_ 1784729551848341504
author Vejrazkova, Daniela
Vankova, Marketa
Vcelak, Josef
Krejci, Hana
Anderlova, Katerina
Tura, Andrea
Pacini, Giovanni
Sumova, Alena
Sladek, Martin
Bendlova, Bela
author_facet Vejrazkova, Daniela
Vankova, Marketa
Vcelak, Josef
Krejci, Hana
Anderlova, Katerina
Tura, Andrea
Pacini, Giovanni
Sumova, Alena
Sladek, Martin
Bendlova, Bela
author_sort Vejrazkova, Daniela
collection PubMed
description BACKGROUND: The MTNR1B gene encodes a receptor for melatonin, a hormone regulating biorhythms. Disruptions in biorhythms contribute to the development of type 2 diabetes mellitus (T2DM). Genetic studies suggest that variability in the MTNR1B gene affects T2DM development. Our aim was to compare the distribution of the genetic variant rs10830963 between persons differing in glucose tolerance in a sample of the Czech population (N=1206). We also evaluated possible associations of the polymorphism with insulin sensitivity, beta cell function, with the shape of glucose, insulin and C-peptide trajectories measured 7 times during a 3-hour oral glucose tolerance test (OGTT) and with glucagon response. In a subgroup of 268 volunteers we also evaluated sleep patterns and biorhythm. RESULTS: 13 persons were diagnosed with T2DM, 119 had impaired fasting blood glucose (IFG) and/or impaired glucose tolerance (IGT). 1074 participants showed normal results and formed a control group. A higher frequency of minor allele G was found in the IFG/IGT group in comparison with controls. The GG constellation was present in 23% of diabetics, in 17% of IFG/IGT probands and in 11% of controls. Compared to CC and CG genotypes, GG homozygotes showed higher stimulated glycemia levels during the OGTT. Homozygous as well as heterozygous carriers of the G allele showed lower very early phase of insulin and C-peptide secretion with unchanged insulin sensitivity. These differences remained significant after excluding diabetics and the IFG/IGT group from the analysis. No associations of the genotype with the shape of OGTT-based trajectories, with glucagon or with chronobiological patterns were observed. However, the shape of the trajectories differed significantly between men and women. CONCLUSION: In a representative sample of the Czech population, the G allele of the rs10830963 polymorphism is associated with impaired early phase of beta cell function, and this is evident even in healthy individuals.
format Online
Article
Text
id pubmed-9207528
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92075282022-06-21 The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics Vejrazkova, Daniela Vankova, Marketa Vcelak, Josef Krejci, Hana Anderlova, Katerina Tura, Andrea Pacini, Giovanni Sumova, Alena Sladek, Martin Bendlova, Bela Front Endocrinol (Lausanne) Endocrinology BACKGROUND: The MTNR1B gene encodes a receptor for melatonin, a hormone regulating biorhythms. Disruptions in biorhythms contribute to the development of type 2 diabetes mellitus (T2DM). Genetic studies suggest that variability in the MTNR1B gene affects T2DM development. Our aim was to compare the distribution of the genetic variant rs10830963 between persons differing in glucose tolerance in a sample of the Czech population (N=1206). We also evaluated possible associations of the polymorphism with insulin sensitivity, beta cell function, with the shape of glucose, insulin and C-peptide trajectories measured 7 times during a 3-hour oral glucose tolerance test (OGTT) and with glucagon response. In a subgroup of 268 volunteers we also evaluated sleep patterns and biorhythm. RESULTS: 13 persons were diagnosed with T2DM, 119 had impaired fasting blood glucose (IFG) and/or impaired glucose tolerance (IGT). 1074 participants showed normal results and formed a control group. A higher frequency of minor allele G was found in the IFG/IGT group in comparison with controls. The GG constellation was present in 23% of diabetics, in 17% of IFG/IGT probands and in 11% of controls. Compared to CC and CG genotypes, GG homozygotes showed higher stimulated glycemia levels during the OGTT. Homozygous as well as heterozygous carriers of the G allele showed lower very early phase of insulin and C-peptide secretion with unchanged insulin sensitivity. These differences remained significant after excluding diabetics and the IFG/IGT group from the analysis. No associations of the genotype with the shape of OGTT-based trajectories, with glucagon or with chronobiological patterns were observed. However, the shape of the trajectories differed significantly between men and women. CONCLUSION: In a representative sample of the Czech population, the G allele of the rs10830963 polymorphism is associated with impaired early phase of beta cell function, and this is evident even in healthy individuals. Frontiers Media S.A. 2022-06-06 /pmc/articles/PMC9207528/ /pubmed/35733780 http://dx.doi.org/10.3389/fendo.2022.868364 Text en Copyright © 2022 Vejrazkova, Vankova, Vcelak, Krejci, Anderlova, Tura, Pacini, Sumova, Sladek and Bendlova https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Vejrazkova, Daniela
Vankova, Marketa
Vcelak, Josef
Krejci, Hana
Anderlova, Katerina
Tura, Andrea
Pacini, Giovanni
Sumova, Alena
Sladek, Martin
Bendlova, Bela
The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics
title The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics
title_full The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics
title_fullStr The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics
title_full_unstemmed The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics
title_short The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics
title_sort rs10830963 polymorphism of the mtnr1b gene: association with abnormal glucose, insulin and c-peptide kinetics
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207528/
https://www.ncbi.nlm.nih.gov/pubmed/35733780
http://dx.doi.org/10.3389/fendo.2022.868364
work_keys_str_mv AT vejrazkovadaniela thers10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics
AT vankovamarketa thers10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics
AT vcelakjosef thers10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics
AT krejcihana thers10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics
AT anderlovakaterina thers10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics
AT turaandrea thers10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics
AT pacinigiovanni thers10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics
AT sumovaalena thers10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics
AT sladekmartin thers10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics
AT bendlovabela thers10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics
AT vejrazkovadaniela rs10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics
AT vankovamarketa rs10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics
AT vcelakjosef rs10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics
AT krejcihana rs10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics
AT anderlovakaterina rs10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics
AT turaandrea rs10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics
AT pacinigiovanni rs10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics
AT sumovaalena rs10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics
AT sladekmartin rs10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics
AT bendlovabela rs10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics